ICHIF(ICHIF)
ICHIF
No analyst ratings available
No analyst price targets available for ICHIF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $103.82B | $110.72B | $117.55B | $121.71B | $123.79B |
| Low | $96.96B | $101.24B | $108.60B | $112.44B | $114.36B |
| High | $111.62B | $118.32B | $125.99B | $130.45B | $132.67B |
| EBITDA Avg | $48.84B | $52.09B | $55.30B | $57.26B | $58.24B |
| Low | $45.62B | $47.63B | $51.09B | $52.90B | $53.80B |
| High | $52.51B | $55.67B | $59.27B | $61.37B | $62.42B |
| EBIT Avg | $48.07B | $51.26B | $54.42B | $56.35B | $57.31B |
| Low | $44.89B | $46.87B | $50.28B | $52.06B | $52.95B |
| High | $51.68B | $54.78B | $58.33B | $60.39B | $61.42B |
| Net Income Avg | $122M | $135M | $148M | $138M | $142M |
| Low | $110M | $121M | $133M | $124M | $128M |
| High | $134M | $147M | $162M | $151M | $156M |
| EPS Avg | $45.89 | $50.57 | $55.49 | $51.87 | $53.52 |
| Low | $41.35 | $45.57 | $50.00 | $46.74 | $48.23 |
| High | $50.17 | $55.29 | $60.67 | $56.71 | $58.52 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $19.99B | $21.97B | $44.73B |
| Low | $19.99B | $21.97B | $44.73B |
| High | $19.99B | $21.97B | $44.73B |
| EBITDA Avg | $9.40B | $10.33B | $21.04B |
| Low | $9.40B | $10.33B | $21.04B |
| High | $9.40B | $10.33B | $21.04B |
| EBIT Avg | $9.25B | $10.17B | $20.71B |
| Low | $9.25B | $10.17B | $20.71B |
| High | $9.25B | $10.17B | $20.71B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |